Edward Nash Analyst Performance

Managing Director at Canaccord Genuity Group

Edward Nash is a stock analyst at Canaccord Genuity Group in the medical sector, covering 19 publicly traded companies. Over the past year, Edward Nash has issued 17 stock ratings, including buy and hold recommendations. While full access to Edward Nash's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Edward Nash's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ranking: Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Success Rate: 00.00% Profitable Ratings
Total Ratings: 43 Last 10 Years
Buy Recommendations: 83.33% 35 Buy Ratings
Companies Covered: 19 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	83.3%	35 ratings
Hold	16.7%	7 ratings
Sell	0.0%	0 ratings

Out of 42 total stock ratings issued by Edward Nash at Canaccord Genuity Group, the majority (83.3%) have been Buy recommendations, followed by 16.7% Hold.

Best & Worst Calls

Best Call
0000.0%
MDGL
May 2022
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
OBSV
Apr 2022
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	94.7% of companies on NASDAQ	18 companies
TSE	5.3% of companies on TSE	1 company

Edward Nash, an analyst at Canaccord Genuity Group, currently covers 19 companies listed on NASDAQ and TSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 19 companies	100.0%

Edward Nash of Canaccord Genuity Group specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED - BIOMED/GENE 9 companies	47.4%
PHARMACEUTICAL PREPARATIONS 4 companies	21.1%
MED - DRUGS 3 companies	15.8%
DRUG MANUFACTURERS - SPECIALTY & GENERIC 1 company	5.3%
BIOTECHNOLOGY 1 company	5.3%
BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC 1 company	5.3%

Timeframe

Start Date

End Date

Rating

12-Month ROIAll ROI

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating
MDGL Madrigal Pharmaceuticals	9/12/2025	Boost Price Target	$439.45	$526.00	Buy
CORT Corcept Therapeutics	9/10/2025	Boost Price Target	$73.48	$140.00	Buy
CLDX Celldex Therapeutics	8/20/2025	Lower Price Target	$22.11	$62.00	Buy
MDGL Madrigal Pharmaceuticals	8/6/2025	Boost Price Target	$335.67	$428.00	Buy
CORT Corcept Therapeutics	8/1/2025	Lower Price Target	$68.52	$137.00	Buy
SGMT Sagimet Biosciences	7/24/2025	Initiated Coverage	$9.59	$28.00	Buy
VRNA Verona Pharma PLC American Depositary Share	7/9/2025	Downgrade	$104.77	$107.00	Hold
MDGL Madrigal Pharmaceuticals	5/2/2025	Boost Price Target	$327.81	$420.00	Buy
CLDX Celldex Therapeutics	4/28/2025	Initiated Coverage	$19.57	$64.00	Buy
TVTX Travere Therapeutics	4/10/2025	Boost Price Target	$13.42	$47.00	Buy
CORT Corcept Therapeutics	4/1/2025	Boost Price Target	$102.62	$142.00	Buy
RANI Rani Therapeutics	2/26/2025	Reiterated Rating	$1.55	$9.00	Buy
VRNA Verona Pharma PLC American Depositary Share	2/12/2025	Boost Price Target	$59.33	$72.00	Buy
TVTX Travere Therapeutics	2/12/2025	Boost Price Target	$23.75	$45.00	Buy
PLRX Pliant Therapeutics	2/10/2025	Reiterated Rating	$7.79	$4.00	Hold
CORT Corcept Therapeutics	1/30/2025	Boost Price Target	$69.89	$130.00	Buy
AKRO Akero Therapeutics	1/28/2025	Boost Price Target	$51.37	$73.00	Buy

Stock Forecasts and Research Tools

Today's Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.